Raise closed, search for fresh raises on Seedstage

Dallas, TX

Advancing patient-specific dental implants through technology and streamlined processes.

• Innovative Implant Solution: Patient-specific implants simplify procedures and reduce recovery time.
• Proven Technology: Over 300 successful implantations and 10 years of clinical data.
• Targeting Growing Market: Positioned in the $5.7 billion dental implant industry.
• Strong Intellectual Property: Extensive patent portfolio protecting unique technologies.
• Focused Commercialization: FDA 510(k) clearance and market expansion plans underway.

RTRS Technologies is conducting a fundraising campaign to advance its innovative dental implant solutions. With a focus on simplifying and improving the dental implant process, RTRS leverages cutting-edge technology to create patient-specific implants that reduce recovery times and enhance outcomes. This investment will support RTRS’s efforts to finalize product validation, achieve FDA clearance for the REPLICATE Tooth 2.0 system, and expand its manufacturing capabilities. The company’s approach eliminates the need for multiple surgeries, providing a streamlined solution for general dentists and patients alike.

Funds raised through this offering will be instrumental in driving RTRS’s commercialization efforts within the $5.7 billion global dental implant market. RTRS plans to use these proceeds for research and development, clinical validation, and scaling its operations. With over a decade of clinical data and more than 300 successful implantations of its first-generation product, the company is positioned to disrupt traditional dental implant practices and broaden access to advanced restorative dental care globally.

Company Info

RTRS Technologies develops customized dental implant systems designed to simplify procedures and improve patient outcomes.

RTRS Technologies is an early-stage medical device company focused on revolutionizing dental implants with the REPLICATE™ Immediate Tooth Replacement System. Utilizing advanced 3D X-ray technology, RTRS creates 100% customized anatomical tooth replacements that fit directly into the extraction socket without drilling or multiple surgeries, reducing recovery time and preserving surrounding bone and tissue. The system simplifies tooth replacement, making it accessible for general dentists and expanding options for patients globally. Backed by a decade of clinical data and 300 successful implantations, RTRS is advancing the development of its second-generation REPLICATE Tooth and preparing for its FDA 510(k) submission.

The company operates a pilot manufacturing facility in Texas and leverages over $27 million in previous investment to accelerate market entry into the $5.7 billion global dental implant industry. By addressing the limitations of traditional dental procedures, RTRS aims to improve patient outcomes while reducing complexity and cost. With a strong patent portfolio and experienced leadership, RTRS is positioned to make a significant impact on the dental implant market.